Detecting targets using mass tags and mass spectrometry

Patent metadata

Field	Value
Publication number	US-10883999-B2
Application number	US-201816055046-A
Country	US
Kind code	B2
Filing date	Aug 4, 2018
Priority date	Jul 2, 2010
Publication date	Jan 5, 2021
Grant date	Jan 5, 2021

Abstract

Particular disclosed embodiments disclosed herein concern using a one or more various mass tags, which can be specifically deposited at targets through direct or indirect enzymatic-catalyzed transformation, to provide a method for identifying targets in tissue samples. The mass tags may be labeled with stable isotopes to produce mass tags having the same chemical structure but different masses. Mass codes produced by ionizing the mass tags are detected and/or quantified using mass spectrometry. The method can be used for multiplexed detection of multiple targets in a particular sample. In some embodiments, a map divided into sections representing sections of the tissue sample may be prepared, with the map sections including data corresponding to quantification data wherein the size of a mass peak is determined and correlated with the amount of a target for the corresponding tissue sample section.

First claim

The invention claimed is:

1. A conjugate having the formula:

wherein the ‘Mass Tag Precursor’ includes a metal-heteroaryl chelate comprising a metal selected from the group consisting of Zn, Ni, Co, Ru, Cd, Pt, and Fe; R 16 is selected from the group consisting of ether, hydroxyl, and -(nitrogen-R 11 )—, R 11 is selected from the group consisting of an aliphatic group, a heteroaliphatic group, an aryl group, a heteroaryl group, and hydrogen; R 17 is selected from the group consisting an aliphatic group, a heteroaliphatic group, an aryl group, and a heteroaryl group; n is an integer ranging from 1 to 20; Y is selected from the group consisting of oxygen, sulfur, and -(nitrogen-R 11 )—; the optional linker is selected from the group consisting of an aliphatic group, a heteroaliphatic group, and a heterobifunctional linker; and the optional carrier is selected from the group consisting of a polymer, a biomolecule, a liposome, a micelle, and a nanoparticle.

2. The conjugate of claim 1 , wherein the metal-heteroaryl chelate has the formula:

where R 29 , R 39 , R 31 , R 32 , and R 33 independently an aliphatic group, a heteroaliphatic group, an aryl group, a heteroaryl group, a carbonyl group, a halogen, a hydrogen, a hydroxyl group, an isothiocyanate group, an isocyanate group, a nitrile group, a nitro group, a thiol, or any combination thereof; M is a metal selected from the group consisting of Zn, Ni, Co, Ru, Cd, Pt, and Fe; rings A, A′, B, B′, C, C′ are optionally bonded to provide a monoheteroaryl chelate, a biheteroaryl chelate, or a terheteroaryl chelate; Y is selected from the group consisting of oxygen, sulfur, and -(nitrogen-R 11 )—; and Z is selected from the group consisting of oxygen, sulfur, and -(nitrogen-R 11 )—, where R 11 is an aliphatic group, a heteroaliphatic group, an aryl group, a heteroaryl group, or hydrogen.

3. The conjugate of claim 2 , wherein the conjugate has any one of the formulas:

4. The conjugate of claim 3 , wherein the metal-heteroaryl chelate has one of the formulas:

Assignees

• Ventana Med Syst Inc

Inventors

• Hong Rui
• Wang Hong
• Lefever Mark
• Froehlich Jan
• Bieniarz Christopher
• Kelly Brian Daniel
• Miller Phillip

Classifications

• G01N33/6848 Primary

  Methods of protein analysis involving mass spectrometry · CPC title

• G01N27/62

  by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode · CPC title